| RS2153015644 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153015709 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153020985 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153021199 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153021628 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153021634 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Hurler syndrome |
| RS2153021698 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153021702 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153021904 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153021921 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153021926 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS2153021976 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153021978 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022009 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022188 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022202 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022225 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022228 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022229 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-I-H/S |
| RS2153022263 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022341 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022349 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022358 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022377 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022390 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022399 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis |
| RS2153022415 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022443 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022646 |
IDUA
|
Health Risk |
Pathogenic |
— |
| RS2153022799 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Hurler syndrome |
| RS2153022881 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS2153022895 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022916 |
IDUA
|
Health Risk |
Pathogenic |
Interstitial pneumonitis, Interstitial pneumonitis |
| RS2153022938 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022944 |
IDUA
|
Health Risk |
Likely pathogenic |
— |
| RS2153022958 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153022990 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153023210 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Hurler syndrome |
| RS2153023278 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS2153023287 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS2153023301 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Hurler syndrome |
| RS2153024257 |
TAOK1
|
Health Risk |
Likely pathogenic |
Developmental delay with or without intellectual impairment or behavioral abnormalities, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2153025020 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153026918 |
TAOK1
|
Health Risk |
Likely pathogenic |
Global developmental delay, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2153026921 |
TAOK1
|
Health Risk |
Likely pathogenic |
— |
| RS2153028697 |
TAOK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Macroglossia, Global developmental delay |
| RS2153028699 |
TAOK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with or without intellectual impairment or behavioral abnormalities, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2153029219 |
TAOK1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2153029597 |
TAOK1
|
Health Risk |
Pathogenic |
Developmental delay with or without intellectual impairment or behavioral abnormalities, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2153030392 |
TAOK1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2153034844 |
CHKA
|
Health Risk |
Likely pathogenic |
Microcephaly, Severe intellectual disability |
| RS2153039957 |
KMT5B
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2153039995 |
KMT5B
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2153040709 |
KMT5B
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2153040748 |
KMT5B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2153041026 |
KMT5B
|
Health Risk |
Likely pathogenic |
— |
| RS2153041094 |
KMT5B
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2153042521 |
HDAC4
|
Health Risk |
Likely pathogenic |
— |
| RS2153051225 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast and/or ovarian cancer, Breast and/or ovarian cancer |
| RS2153052061 |
KMT5B
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2153052073 |
KMT5B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2153052371 |
KMT5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2153054646 |
KMT5B
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2153055850 |
KMT5B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2153068015 |
KMT5B
|
Health Risk |
Pathogenic |
Autistic behavior, Autistic behavior |
| RS2153069688 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2153070428 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2153072192 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Nemaline myopathy 2 |
| RS2153073575 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153073717 |
MEF2C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2153074000 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2153074006 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153074319 |
MEF2C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2153074738 |
MEF2C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2153074771 |
MEF2C
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2153074822 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2153075593 |
BRCA1
|
Health Risk |
Likely pathogenic |
— |
| RS2153082051 |
NBEA
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2153082059 |
NBEA
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2153085709 |
BRCA1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2153102752 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153104173 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153110162 |
LRP5
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2153110244 |
LRP5
|
Health Risk |
Likely pathogenic |
— |
| RS2153112725 |
PHOX2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Haddad syndrome |
| RS2153112779 |
PHOX2B
|
Health Risk |
Likely pathogenic |
Haddad syndrome, Hereditary cancer-predisposing syndrome |
| RS2153112821 |
PHOX2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital central hypoventilation, Hereditary cancer-predisposing syndrome |
| RS2153112938 |
PHOX2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2153113036 |
PHOX2B
|
Health Risk |
Likely pathogenic |
Haddad syndrome, Neuroblastoma |
| RS2153113037 |
PHOX2B
|
Health Risk |
Pathogenic |
Congenital central hypoventilation, Congenital central hypoventilation |
| RS2153113084 |
PHOX2B
|
Health Risk |
Pathogenic |
Haddad syndrome, Hereditary cancer-predisposing syndrome |
| RS2153115303 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153129403 |
LRP5
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2153129468 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2153129564 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2153136142 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2153138452 |
SLC30A9
|
Health Risk |
Likely pathogenic |
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome, Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome |
| RS2153138545 |
RBL2
|
Health Risk |
Likely pathogenic |
Brunet-Wagner neurodevelopmental syndrome, Brunet-Wagner neurodevelopmental syndrome |
| RS2153139453 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2153140527 |
LRP5
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |